Boehringer Ingelheim’s Me-Too Petition Against Generic Spiriva
This article was originally published in The Pink Sheet Daily
Executive Summary
The company is borrowing a page, and a law firm, from GlaxoSmithKline’s 2009 citizen petition asking FDA to impose conditions on generic Advair.
You may also be interested in...
FDA Generics Director’s Departure Shows Why Chemistry Matters
Another outside candidate is expected to eventually take over for the departing director Gregory Geba, and while the Office of Generic Drugs can run smoothly without a permanent leader for now, it cannot do so forever.
New COPD Candidates Could Get Hung Up On Safety Concerns
FDA is facing several novel candidates for chronic obstructive pulmonary disease in 2013; those products should expect close scrutiny due to past issues with class safety and new signals in clinical trials.
New COPD Candidates Could Get Hung Up On Safety Concerns
FDA is facing several novel candidates for chronic obstructive pulmonary disease in 2013; those products should expect close scrutiny due to past issues with class safety and new signals in clinical trials.